Kansas City Star |
FDA rejects muscular dystrophy drug, says it doesn't work
ABC News FILE - This Oct. 14, 2015, file photo, shows the U.S. Food & Drug Administration campus in Silver Spring, Md. On Wednesday, Oct. 25, 2017, the FDA rejected an experimental drug for a common type of muscular dystrophy. The drug from PTC Therapeutics ... Family of 10-year-old with rare genetic disease hopes for FDA approval of life-extending drug The FDA rejects a questionable drug — and shows its vaunted flexibility has limits |
from Health - Google News http://ift.tt/2y3Khd6
EmoticonEmoticon